Although overall CV mortality has declined in recent years, patients with clinically manifest CVD remain at increased risk of recurrent CV events. A group of HCPs at UK primary and secondary care centres have recently developed a consensus statement to improve delivery of secondary prevention in the UK.
![Antihypertensives](https://www.issuesandanswers.org/wp-content/uploads/2022/07/header-B2B-antihypertensives-150x100.jpg)